SciSparc Signs Agreement for the Supply of CBD-rich Cannabis Oil for its Clinical Trial on Children with Autism Spectrum Disorder

MMP News AuthorFebruary 27, 2023
The cannabis oil will be used as a part of the Company‘s proprietary SCI-210 treatment combination of CBD and CannAmide™  TEL AVIV, Israel, Feb. 27, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of  ... Read More

Sanctuary Clinics Provides Christian-Based Marijuana Treatme…

MMP News AuthorJune 1, 2022
(MENAFN– GetNews) Sanctuary Clinics, a reliable Christian-focused mental health and recovery center, offers marijuana addiction treatment programs. Overcoming addiction and mental health problems can easily and effectively be achieved with the help of treatment centers committed to providing trusted recovery solutions. Sanctuary Clinics is a Christian-based and Christ-centered behavioral health ... Read More

Cannabis Watch: GW Pharma shares rally on earnings and news of late-stage trial of cannabis-based treatment for MS patients

MMP News AuthorNovember 3, 2020
Shares of GW Pharmaceuticals PLC jumped 18% Tuesday, after the biotech posted a narrower-than-expected third-quarter loss and a revenue beat and said a delayed late-stage trial of its cannabinoid-based treatment for multiple sclerosis spasticity can now proceed. Volume of 2.14 million shares traded was 5.5 times the 65-day average of ... Read More

Israeli company achieves success in possible cannabis treatment

MMP News AuthorSeptember 30, 2020
Canassure, an Israeli company that focuses on medical cannabis research, announced the successful completion of the first stage of research meant to examine the effects of the plant on skin-related diseases.  The fruit of ongoing cooperation between Canassure and a Swedish company named Lipidor, the research examined the possibility of ... Read More